![]() All the consent documents contained specific information about the respective genomic study, including purpose, risks, benefits, compensation, and access to health records. The experimental consent templates were adapted for each genomic study. During the debriefing, participants were given information about the consent study and the randomization process, a detailed review of the data sharing options in each experimental consent document, and an opportunity to change their data sharing choice. Twenty-seven participants did not return for a follow-up visit and were debriefed by phone or US mail. Debriefing took place either in a private hospital room during an inpatient stay or in a waiting or examination room during a follow-up clinic visit. One individual reportedly refused participation in the genomic study specifically because of concerns about data sharing and was debriefed by a consent study coordinator. Those who were ineligible or declined participation in the genomic study but had seen or signed one of our experimental consent documents were debriefed by the genomic study PI or research nurse most refusals were due to general research concerns (e.g., fear of blood draw) or lack of time. After providing informed consent for the genomic study, participants were debriefed by a designated research coordinator from this consent study.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |